Clinical trial

Sacubitril-valsartan Versus Usual Anti-hypertensives in LVAD

NCT03279861

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Entresto Normalized identity: EntrestoView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Valsartan Normalized identity: valsartanView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Sacubitril-valsartan Versus Usual Anti-hypertensives in LVAD

Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2017-11-01

PhasePHASE4

Conditions

Congestive Heart Failureverified · MONDO: congestive heart failure

Hypertensionunresolved

Interventions

EntrestoDRUG · verified · RxNorm: Entresto

ValsartanDRUG · verified · RxNorm: valsartan

Sponsors & collaborators

University of Maryland, Baltimorelead sponsor

Medtroniccollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03279861 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.